Arrowstreet Capital, Limited Partnership United Therapeutics Corp Transaction History
Arrowstreet Capital, Limited Partnership
- $136 Billion
- Q2 2025
A detailed history of Arrowstreet Capital, Limited Partnership transactions in United Therapeutics Corp stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 339,092 shares of UTHR stock, worth $102 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
339,092
Previous 398,230
14.85%
Holding current value
$102 Million
Previous $123 Million
20.63%
% of portfolio
0.07%
Previous 0.1%
Shares
23 transactions
Others Institutions Holding UTHR
# of Institutions
743Shares Held
43.9MCall Options Held
159KPut Options Held
151K-
Black Rock Inc. New York, NY5.47MShares$1.65 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.45MShares$1.34 Billion0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.37MShares$714 Million12.42% of portfolio
-
State Street Corp Boston, MA2.17MShares$653 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.12MShares$639 Million0.86% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $13.7B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...